Beyond the AI Pilot: The 2026 Healthcare Fight for Patient Loyalty

Becker’s Dental Review
April 13, 2026

Read Full Article →

AI-Generated Summary

Dr. Barry Lyon identifies the core reputational problem for DSOs: patients associate corporate dentistry with private equity ownership, production quotas, and prioritizing revenue over relationships. Patients want convenience and affordability but distrust the model. Lyon argues that transparent outcomes data and ongoing provider support are the most credible paths to rebuilding trust.

Why It Matters

DSOs that ignore the reputational gap between patient expectations and corporate dentistry’s image are leaving both patient volume and provider retention on the table.

corporate dentistry
patient trust
DSO reputation
private equity perception
transparency
provider relationships

While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.

INVOCA
May 14, 2026

Read Full Article ?

AI-Generated Summary

With the Medicaid and ACA coverage cliffs shrinking the patient base, 63% of patients say they would switch providers over poor communication — and 47% have avoided scheduling an appointment because calling felt like too much effort. Invoca’s research argues that healthcare organizations stuck in “AI pilot mode” are missing the real prize: using AI to close communication gaps that drive patient attrition. The piece examines how agentic AI is reducing interaction abandonment at the scheduling stage, why call conversion is now a margin-protection strategy, and how leading health systems are moving from experimentation to full deployment of AI-powered patient engagement. Practical benchmarks and ROI framing included.

Frequently asked questions

Why do patients distrust DSO and corporate dental practices?

Research cited by Dr. Barry Lyon points to three primary drivers: patient perception that private equity ownership creates production quotas, concern that revenue targets override clinical judgment, and a lack of transparent outcomes data. These associations persist even when the clinical quality at a given location is high.

How can DSOs rebuild patient trust and improve brand reputation?

Lyon argues that transparent outcomes data and sustained provider support are the most credible paths forward. Publishing actual clinical outcomes — rather than relying on brand advertising — and ensuring consistent, relationship-oriented care can counter the corporate dentistry stigma that suppresses patient retention and new patient conversion.

How does DSO reputation affect provider recruitment?

The reputational gap between patient expectations and corporate dentistry’s image affects not only patient volume but also the ability to recruit and retain dentists. DSOs that fail to address brand perception risk losing both patients and clinical talent to independent competitors who can offer a different practice identity.

Similar Posts

  • CMS Proposes 2027 Physician Payment Overhaul: MIPS Sunset and ACO Expansion

    CMS’s proposed CY 2027 Physician Fee Schedule rule would sunset traditional MIPS reporting in 2029, replace it with specialty-focused MIPS Value Pathways covering roughly 98% of specialties, and make Medicare ACOs easier to join and more rewarding. The Medicare Shared Savings Program — which paid $4.1 billion in shared savings to 75% of its 476 ACOs for 2024 while generating about $2.5 billion in net Medicare savings — would gain new-entrant financial incentives, more predictable spending benchmarks, and the option to reduce beneficiary cost-sharing starting April 2027. CMS also proposes recalibrating physician payment rates, introducing MIPS Core Measures in 2027, and closing an APM incentive loophole worth an estimated $2.38 billion over a decade.

  • The Attribution Problem Your Board Doesn’t Understand

    Healthcare marketing attribution is genuinely hard for multi-site groups because patient journeys are long, largely offline, and privacy-constrained—and a budget you can’t defend is a budget that gets cut. Strategy Collective’s Matt Lee argues perfect attribution doesn’t exist, but ‘good enough’ attribution is achievable through four moves: call tracking, redesigned patient intake questions, a blended market-level report, and separating brand demand from generated demand. The bigger fix is reframing the board conversation itself. Instead of asking ‘is marketing working?’, leaders should ask ‘how do we make Market B look like Market A?’—shifting from an unwinnable ROI-proof debate to a comparative, market-level view that drives real reallocation decisions.

  • Q3 2026 AI Trends: What Growth Leaders Need to Track

    The most useful AI question for growth-stage leaders in Q3 2026 has shifted from what models can do to what results they actually deliver. Summit Partners’ AI and data science team flags five developments to track: the conversation has moved from capability to production results; the binding constraint is rarely the model itself but data, workflow, and integration; agents are evolving from assistants to actors, with trust as the real limiting factor; the underlying economics of AI are being rewritten; and leaders must separate genuine signal from noise while recognizing what work stays human. The throughline is disciplined execution—turning promising pilots into dependable, measurable production systems.

  • PE’s Quieter Playbook: Joint Ventures With Nonprofit Health Systems

    Private equity firms are increasingly expanding in healthcare through joint ventures with nonprofit health systems rather than outright buyouts, according to a new report from the Private Equity Stakeholder Project. The report finds 21.4% of private equity-owned hospitals are held through joint venture arrangements with nonprofit systems, and the structure now spans hospitals, inpatient rehab, hospice, home health, behavioral health, ambulatory surgery centers and urgent care — likely an undercount, since the tally covers only publicly identifiable arrangements. Case studies include ventures involving Lifepoint Health, Compassus, Ardent Health Services and Ascension. PESP argues these JVs have drawn far less scrutiny than traditional PE buyouts even as they become more common, prompting calls for greater oversight.

  • Why Penn Medicine Is Deploying AI Agents for Patient Intake

    Penn Medicine is integrating K Health’s AI-powered patient intake agents into its virtual primary care service, testing whether an AI ‘team member’ in the patient-provider relationship improves outcomes. The agents collect symptoms and medical history before a visit and convert them into structured summaries that feed directly into the clinician’s existing workflow — providers start appointments already informed, and patients get routed to the right level of care. The same K Health technology already runs inside virtual care programs at Cedars-Sinai, Mayo Clinic, Mass General Brigham and Hartford HealthCare, with use cases ranging from new-patient acquisition to expanding primary care access. If the pilot succeeds, Penn plans to extend the agents into in-person primary care offices and specialty clinics.

  • Patient Portal Messages Have Surged 153% Since COVID, JAMA Study Finds

    Patient-authored messages to providers have surged 153% since the COVID-19 pandemic, and a new JAMA study using Epic data finds the increase did not reduce telehealth or in-person visits. The authors conclude that patient messaging functions as an expansion of between-visit care rather than a substitute for it, and that the steady, gradual rise makes the trend likely to persist. Messaging was most common among female patients, patients aged 40 to 64, and those in affluent neighborhoods. The operational cost is significant: the AMA reports inbox overload is now a leading driver of physician burnout, with some physicians spending up to two hours nightly clearing their in-basket, and burnout conservatively costing health systems over $5 billion a year.